Genetic polymorphisms of cytochromes P450: CYP2C9, CYP2C19, and CYP2D6 in Croatian population

被引:0
|
作者
Bozina, N
Granic, P
Lalic, Z
Tramisak, I
Lovric, M
Stavljenic-Rukavina, A
机构
[1] Univ Zagreb, Ctr Hosp, Univ Inst Lab Diag, Zagreb 10000, Croatia
[2] Sch Med, Zagreb, Croatia
关键词
alleles; Croatia; cytochrome P450 enzyme system; genotype; phenotype; polymorphism (genetics);
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aim. To determine the prevalence of most common mutations of cytochrome P450 (CYP), ie, allelic variants of CYP2C9, CYP2C19, and CYP2D6, and to predict genotype frequency in the Croatian population. Methods. CYP genotype was determined in 200 non-related Croatian citizens. DNA isolated from blood samples was used for the analysis of the most common allelic variants of CYP2C9, CYP2C19, and CYP2D6 by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) method. Results. For 200 subjects genotyped for CYP2C9, the allele frequencies of CYP2C9*1 (wt), CYP2C9*2, and CYP2C9*3 were 0.74 0.165 and 0.095, respectively. Among them, 3.5% of subjects were predicted to be poor metabolizers. For CYP2C19, the most frequent alleles were CYP2C19*1 and CYP2C19*2, with frequencies of 0.85 and 0.15 respectively; 3% of subjects were predicted to be poor metabolizers. For CYP2D6, the most frequent alleles were CYP2D6*1 (frequency 0.765), CYP2D62* (0.04), CYP2D6*3 (0.0275), CYP2D6*4 (0.14), CYP2D6*5 (0.01), and CYP2D6*6 (0.015). Out of these, 3% were predicted to be poor metabolizers, and 4% were predicted to be ultra-rapid metabolizers. Conclusion. The prevalence of allelic variants and predicted genotypes in the Croatian population is in accordance with the other European populations, and it can be interpolated between the values for mid-European and Mediterranean populations.
引用
收藏
页码:425 / 428
页数:4
相关论文
共 50 条
  • [1] The Effect of Genetic Polymorphisms of Cytochrome P450 CYP2C9, CYP2C19, and CYP2D6 on Drug-Resistant Epilepsy in Turkish Children
    Seven, Mehmet
    Batar, Bahadir
    Unal, Selin
    Yesil, Gozde
    Yuksel, Adnan
    Guven, Mehmet
    MOLECULAR DIAGNOSIS & THERAPY, 2014, 18 (02) : 229 - 236
  • [2] CYP2C9, CYP2C19 and CYP2D6 allele frequencies in the Ashkenazi Jewish population
    Scott, StuartA
    Edelmann, Lisa
    Kornreich, Rutb
    Erazo, Monica
    Desnick, Robert J.
    PHARMACOGENOMICS, 2007, 8 (07) : 721 - 730
  • [3] Genomic Ancestry, CYP2D6, CYP2C9, and CYP2C19 Among Latin Americans
    Rodrigues-Soares, Fernanda
    Penas-Lledo, Eva M.
    Tarazona-Santos, Eduardo
    Sosa-Macias, Martha
    Teran, Enrique
    Lopez-Lopez, Marisol
    Rodeiro, Idania
    Moya, Graciela E.
    Calzadilla, Luis R.
    Ramirez-Roa, Ronald
    Grazina, Manuela
    Estevez-Carrizo, Francisco E.
    Barrantes, Ramiro
    LLerena, Adrian
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2020, 107 (01) : 257 - 268
  • [4] Pharmacogenetic Prediction of Individual Variability in Drug Response Based on CYP2D6, CYP2C9 and CYP2C19 Genetic Polymorphisms
    Chaudhry, Shafqat Rasul
    Muhammad, Sajjad
    Eidens, Moritz
    Klemm, Marco
    Khan, Dilaware
    Efferth, Thomas
    Weisshaar, Maria-Paz
    CURRENT DRUG METABOLISM, 2014, 15 (07) : 711 - 718
  • [5] Genetic variability of CYP2D6, CYP2B6, CYP2C9 and CYP2C19 genes across the Italian Peninsula
    Carano, Francesco
    Sarno, Stefania
    De Fanti, Sara
    Serventi, Patrizia
    Bini, Carla
    Luiselli, Donata
    Pelotti, Susi
    ANNALS OF HUMAN BIOLOGY, 2018, 45 (01) : 66 - 71
  • [6] Relevance of the ancestry for the variability of the Drug-Metabolizing Enzymes CYP2C9, CYP2C19 and CYP2D6 polymorphisms in a multiethnic Costa Rican population
    Cespedes-Garro, Carolina
    Rodrigues-Soares, Fernanda
    Jimenez-Arce, Gerardo
    Naranjo, Maria-Eugenia G.
    Tarazona-Santos, Eduardo
    Farinas, Humberto
    Barrantes, Ramiro
    Llerena, Adrian
    REVISTA DE BIOLOGIA TROPICAL, 2016, 64 (03) : 1067 - 1076
  • [7] Genetic polymorphisms of CYP2C9 and CYP2C19 in the Beninese and Belgian populations
    Allabi, AC
    Gala, JL
    Desager, JP
    Heusterspreute, M
    Horsmans, Y
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2003, 56 (06) : 653 - 657
  • [8] Genetic and phenotypic frequency distribution of CYP2C9, CYP2C19 and CYP2D6 in over 3200 Han Chinese
    He, Li
    Chen, Shaojun
    Li, Jingao
    Xie, Xiaoxue
    Huang, Lihua
    Kuang, Yun
    Xu, Kangwei
    Huang, Wanxia
    Zhao, Yanling
    Yang, Guoping
    Guo, Chengxian
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2020, 47 (10) : 1659 - 1663
  • [9] Characterizing the Effect of Cytochrome P450 (CYP)2C8, CYP2C9, and CYP2D6 Genetic Polymorphisms on Stereoselective N-demethylation of Fluoxetine
    Wang, Zhangting
    Wang, Shengjia
    Huang, Minmin
    Hu, Haihong
    Yu, Lushan
    Zeng, Su
    CHIRALITY, 2014, 26 (03) : 166 - 173
  • [10] Impact of CYP2D6, CYP3A5, CYP2C9 and CYP2C19 polymorphisms on tamoxifen pharmacokinetics in Asian breast cancer patients
    Lim, Joanne S. L.
    Chen, Xiang A.
    Singh, Onkar
    Yap, Yoon S.
    Ng, Raymond C. H.
    Wong, Nan S.
    Wong, Mabel
    Lee, Edmund J. D.
    Chowbay, Balram
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2011, 71 (05) : 737 - 750